Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001215121 | SCV001386847 | uncertain significance | Hereditary spastic paraplegia 48 | 2022-07-27 | criteria provided, single submitter | clinical testing | This sequence change affects codon 208 of the AP5Z1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the AP5Z1 protein. This variant is present in population databases (rs772392202, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. ClinVar contains an entry for this variant (Variation ID: 944670). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome Diagnostics Laboratory, |
RCV001847193 | SCV002106206 | uncertain significance | Hereditary spastic paraplegia | 2021-05-12 | criteria provided, single submitter | clinical testing |